Corentec Co

Corentec Co Short-term Debt

The Short-Term Debt of Corentec Co (104540.KQ) as of Nov 7, 2026 is 21.40 B KRW. In the previous year, Short-Term Debt was 15.56 B KRW — a change of 37.51% (higher).

Short-term Debt

21.40 BKRW

YoY

37.51%

Last updated:

Short-Term Debt of Corentec Co is 2024 21.40 B KRW. Short-Term Debt of Corentec Co was 2023 15.56 B KRW. It decreases by 37.51% higher compared to the previous year.

The Corentec Co Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2017
150.00 KRW
Jan 1, 2018
579.71 M KRW
Jan 1, 2019
10.06 B KRW
Jan 1, 2020
17.39 B KRW
Jan 1, 2021
11.70 B KRW
Jan 1, 2022
13.43 B KRW
Jan 1, 2023
15.56 B KRW
Jan 1, 2024
21.40 B KRW
The Corentec Co Short-term Debt history
YEARShort-term DebtYoY
21.40 BKRW+37.51%
15.56 BKRW+15.89%
13.43 BKRW+14.78%
11.70 BKRW-32.73%
17.39 BKRW+72.97%
10.06 BKRW+1,634.65%
579.71 MKRW+386.47 M%
150.00KRW-100.00%
317.26 MKRW-94.45%
5.72 BKRW-29.68%
8.13 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Short-Term Debt of Corentec Co is 21.40 B KRW in 2024.

Short-Term Debt of Corentec Co changed from 15.56 B KRW to 21.40 B KRW, representing a 37.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Corentec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Corentec Co

All Key Metrics — Corentec Co